Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRIFAROTENE vs TRIMEPRAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRIFAROTENE vs TRIMEPRAZINE: Safety Overview

Metric TRIFAROTENE TRIMEPRAZINE
Total FAERS Reports 112 3,601
Deaths Reported 2 548
Death Rate 1.8% 15.2%
Hospitalizations 1 2,280
Average Patient Age 26.3 yrs 43.9 yrs
% Female Patients 84.4% 57.1%
FDA Approval Date Oct 4, 2019 Approved Prior to Jan 1, 1982
Manufacturer Galderma Laboratories, L.P. N/A
Route TOPICAL N/A
Marketing Status Prescription Discontinued